AnnouncementSep 2026
Sep 2026 · Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 23 Sep - Intimation of Investor/Analyst meet is scheduled to be held on Monday, September 28, 2026
Source: Bse
Fineotex Chemical Limited (FCL)
Small CapIndustrials stocks · Small cap · NSE
Fineotex Chemical Limited operates in Specialty Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.
Data qualityFresh enough for analysisQuote updated 19 Oct, 03:31 pm ISTDetails
Quote19 Oct, 03:31 pm IST
Base fundamentals06 Oct 2026 · screener
Latest result23 Jul, 11:53 pm IST
Score20 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags02 May 2026
Coverage14/14 · 100%
Valuation2026-07-20 · Rf 6.8% · Industrials P/E 26.2 (n=537)
Technical timing lens
Trend score and candlestick chart
59NeutralSMA20 +8.9% / mo · MACD − · near 52W high
Stock trend: 65
Sector RS: 50
Sector 3M: -6.3% vs Nifty 500 -5.6%
Industrials FPI tailwindNot confirmed
Latest mapped FPI equity flow was not positive. View sector evidence
Technical chart
FCLD candles · FIT view+143.6%Latest close ₹55.81 on 2026-10-19
Bar
-1.5%
RSI
50
MACD hist
-0.44
52W pos
85%
2026-10-19O ₹56.67H ₹56.96L ₹55.32C ₹55.81Vol 1.3Cr sh
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context
Relative performance and chart statistics
Adjusted completed-session prices, rebased to 100
FCLNifty India ManufacturingNifty 500
- FCL
- +41.7%
- Nifty 500
- -5.6%
- Nifty India Manufacturing
- -5.8%
- Vs Nifty 500
- +47.3 pp
Chart stats
19 Oct 2026- From 52W high
- -10.6%
- 52W range position
- 85%
- ATR (14)
- 5.8%
- Volume vs 20D
- 0.53x
- Avg traded value
- ₹140 Cr
- 20D price channel
- ₹53.2 - ₹61.4
₹62.4
₹19.1 - ₹62.4
₹3.2
Latest completed session
20-session average
61.9% annualized volatility
Research snapshot
What the evidence says now
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is consistent.
Suggested next step
Research, do not rush
The evidence is not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
Legacy · WATCHLIST33
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Latest result
Good72
Revenue +175.2% · PAT +92.0% YoY
Technical
Neutral59
Price trend and sector-relative-strength timing.
Valuation
Legacy model-34.0%
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Trust
Limited evidence75
Financial-only signal; management claim evidence is not sufficient yet.
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Latest result
Quarter ended 30 Jun 2026
Good · 72/100Rev +175% YoY · PAT +92% YoY · +20% QoQ · margin compression
Filed 23 Jul 2026
Open results browser →| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹377 Cr | +175.2% | +20.1% |
| EBITDA | ₹59 Cr | +136.0% | +34.1% |
| Operating margin | 16.0% | -200 bps | +200 bps |
| PAT | ₹48 Cr | +92.0% | +9.1% |
| PAT margin | 12.7% | -552 bps | -128 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Fundamentals
Valuation
- P/E
- 51.40
- P/B
- 7.12
- EV/EBITDA
- 34.22
- Market Cap
- 6288.00Cr
Profitability
- ROE
- 13.50%
- ROCE
- 18.30%
- ROA
- 12.77%
- Dividend Y
- 0.24%
Growth (CAGR)
- Revenue 5Y
- 29.00%
- EPS 5Y
- 21.00%
- Revenue 3Y
- 14.00%
- EPS 3Y
- 7.00%
Balance Sheet
- Debt/Equity
- 0.01
- Interest Coverage
- 169.00×
- Altman Z
- 8.55
- Book Value
- 7.58
Cash Flow
- FCF Yield
- 1.42%
- FCF Positive Y
- 9/5
- OCF
- -24.00 Cr
- EPS TTM
- 1.06
Shareholding
- Promoter Hold
- 62.30%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 81%
Financial History
Updated 20/10/2026
Revenue
₹ CrLatest: 772+44.8% vs prev
Net Profit
₹ CrLatest: 125+14.7% vs prev
Return on Equity
%Latest: 14.2-5.0% vs prev
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Daily technical trend read
Mixed signalsSignals are conflicting — long-term uptrend intact. RSI 50. Wait for confirmation.
- Price above SMA200 (long-term uptrend) but mid-term MAs not aligned.
- SMA20 rising (~8.2% over last month) — short-term momentum positive.
- RSI(14) at 50 — falling, no extreme reading.
- MACD below signal, histogram expanding negatively — bearish momentum building.
- 11% off 52W high · 192% above 52W low.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Nifty 500 leadership
Relative Strength & Trend Stage
97
RS percentile
Stage 2 UptrendEstablished S2
1M return
-2.1%
3M return
+41.7%
6M return
+142.1%
1Y return
+118.5%
RS 1D
0
RS 20D
+1
Sector rank
#2
Industry rank
#9
Stage evidence
- Price is 42.2% above the 30-week proxy.
- The 50-DMA is above the 30-week proxy and its slope is rising +13.3%.
- Both 3-month and 6-month returns are positive.
50-DMA
price above
200-DMA
price above
S2 entered
25 May 2026
S2 age
104 trading sessions
Sector
leading
Industry
leading
Relative-strength line vs Nifty 500 (base 100)
262 observations
19 Oct 2026Value 229.64-1.51%
RS vs Nifty 500230
Valuation & peers
U-Score 33 · legacy U-Score band WATCHLIST · valuation evidence and comparable companies
Valuation & peers
U-Score 33 · legacy U-Score band WATCHLIST · valuation evidence and comparable companies
WATCHLIST
Fundamental score breakdown
U band · WATCHLISTValuation0/30
Growth12/25
Quality3/20
Balance Sheet11/15
Cash Flow4/10
Piotroski
6/9 (+3)
Penalties
0
Raw sum
33
Why this score?
Top U-Score contributors and drags from the latest stored fundamentals.
33/100 · legacy band WATCHLIST
Positive drivers
- Balance sheet contributes 11/15 to the score.
- Growth contributes 12/25 to the score.
- Cash flow contributes 4/10 to the score.
Main drags
- Fair-value margin of safety is negative at -34.0%.
- Valuation is weaker at 0/30; verify the latest quarterly trend.
- Quality is weaker at 3/20; verify the latest quarterly trend.
Sector valuation model
Cyclical valuation: normalized earnings, not just trailing PE
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
51.4
PB
7.1
EV/EBITDA
34.2
ROE
13.5%
ROCE
18.3%
FCF Yield
1.4%
Debt/Equity
0.0
MoS
-34.0%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Stored run: 20 Oct 2026
v4.3-runtime-valuation
Final score
33
Previous: 33
Legacy U-Score band
WATCHLIST
Previous: WATCHLIST
Margin of safety
-34.0%
Previous: -34.0%
Score history
12 stored score snapshots. Latest stored move: +0 points.
20 Oct 2026
v4.3-runtime-valuation
33
33
33
33
33
33
33
33
33
33
33
33
Factor attribution
No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.
Modelled fair value
Graham Number
₹13.45
-315.1% MoS
Growth-justified P/E
39.3
Growth-justified Value
₹41.66
-34.0% MoS
PEG
3.34
Comparable companies
Peers
Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
TATVA
Small
Tatva Chintan Pharma Chem Limited
Specialty Chemicals
match 164
19
70.8
5.5%
-1191%
OVERVALUED
VINATIORGA
Small
Vinati Organics Limited
Specialty Chemicals
match 162
52
26.2
14.9%
+41%
FAIR VALUE
JGCHEM
Small
J.G.Chemicals Limited
Specialty Chemicals
match 161
43
31.8
13.2%
+19%
WATCHLIST
PAUSHAKLTD
Small
Paushak Limited
Specialty Chemicals
match 160
24
43.1
7.0%
-419%
OVERVALUED
IGPL
Small
IG Petrochemicals Limited
Specialty Chemicals
match 160
30
20.9
0.2%
-3623%
OVERVALUED
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business and thesis
Issuer presentation review pending
Fineotex Chemical Limited operates in Specialty Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 30 Jun 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.
Trust Score
75Limited evidence · low confidenceTrust Lite
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 78th percentile of the scored universe and 76th percentile within Industrials. Main check: financial discipline is weak at 50/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Computed 05 Sept 2026
management-trust-v1
218 docs text-extracted · 59 concalls text-extracted
Score band
Limited evidence
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
Relative rank
78th percentile
overall median 67 · Industrials: 76th pctile, median 68 · Small: 80th pctile, median 66
Evidence depth
Financial-only
218 documents have extracted text, but claim history is not strong enough yet.
Claim delivery
Outcome history still building
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Limited evidence · low confidenceWhat it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Can support position sizing if valuation and trend also agree.
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Promoter
86
strong · holding, pledge, alignment
Cash flow
62
acceptable · profit to cash conversion
Balance sheet
96
strong · leverage and solvency
Discipline
50
watch · capital discipline
Results
87
strong · quarterly consistency
Trust positives
- ▸Promoter holding is 62.3%.
- ▸Promoter pledge is zero.
- ▸FCF yield is positive at 1.5%.
- ▸9 years of positive FCF.
Trust risks
- ▸Operating cash flow is negative at ₹-24 Cr.
- ▸ROCE trend is -8.7%.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Continue researching Fineotex Chemical Limited
Important announcements & filings
Latest exchange and company disclosures found within the past two years.
Open source ↗
AnnouncementSep 2026
Sep 2026 · Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 8 Sep - Fineotex Chemical to attend Anand Rathi G-200 Summit investor meet on September 22, 2026 in Mumbai.
Source: Bse
AnnouncementSep 2026
Sep 2026 · Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 8 Sep - Plant Visit of an Investor group scheduled on September 11, 2026
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Restructuring 24 Sep - Fineotex Biotex HealthGuard FZE incorporated wholly owned step-down subsidiary Fineotex America Inc. in Delaware, USA.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Restructuring 1 Sep - Fineotex Chemical's subsidiary incorporated Fineotex Holdings Inc. in Delaware, USA, as a wholly owned step-down subsidiary.
Source: Bse
Credit rating
Announcement under Regulation 30 (LODR)-Credit Rating 24 Aug - ICRA upgrades Fineotex long-term rating to AA- Stable; short-term A1+ reaffirmed.
Source: Bse
Annual report
Announcement under Regulation 30 (LODR)-Newspaper Publication 19 Aug - Newspaper Advertisement of the Notice of 23rd Annual General Meeting, Annual Report and E-Voting information
Source: Bse
Investor presentationJul 2026
Jul 2026 · PPT
Source: Bse
Concall transcriptJul 2026
Jul 2026 · Transcript
Source: Bse
Investor presentationJul 2026
Jul 2026 · PPT
Source: Bse
AnnouncementJul 2026
Jul 2026 · Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 20 Jul - Fineotex Chemical schedules Q1 FY27 earnings conference call on July 24, 2026 at 5:00 PM IST.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 30 Jun
Source: Bse
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.